Skip to main content
. 2015 Feb 9;10:1045–1059. doi: 10.2147/IJN.S73303

Figure 1.

Figure 1

Peptide (IK8L) decreased mortality rates and disease severity in Kp-infected mice.

Notes: (A) Whole animal imaging of bioluminescence was obtained using IVIS XRII system at different time points. Sham- and IK8L-treated mice were infected with 1×105 CFU of Kp Xen-39 by nasal cavity (Caliper) (arrows indicating Kp spread regions). (B) Kaplan–Meier survival curves were obtained (P=0.0455; 95% confidence interval: 1.041 to 52.46, log-rank test). (C) Bacterial burdens (CFU) of Kp-infected mice treated with IK8L or control at different times. In (A), data are shown as mean ± SD/SEM of n=4 mice per group; (AC) are representative of four mice per group. ***P<0.001; Mann–Whitney U-test.

Abbreviations: CFU, colony-forming units; h, hours; Kp Xen-39, ; Max, maximum; Min, minimum; RLU, relative LUC units; LUC, luminescence unit counts; SD, standard deviation; SEM, standard error of the mean.